Bayer Cropscience Ltd. key Products/Revenue Segments include Insecticides, Pesticides, Herbicides, Weedicides & Fungicides, Other Operating Revenue, Scrap and Royalty Income for the year ending 31-Mar ...

Learn more about whether Ionis Pharmaceuticals, Inc. or PTC Therapeutics, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Roundup's label has a pesticide warning approved by the U.S. Environmental Protection Agency. The bill declares the existing label "sufficient to satisfy any requirement for a warning label regarding ...

The settlement with 15 states will resolve lawsuits alleging the drug OxyContin caused the opioid epidemic. ( Reuters) Bayer ...

Kepler Capital analyst Christian Faitz maintained a Hold rating on Bayer (0P6S – Research Report) on January 21 and set a price target of ...

The pharmaceutical company’s latest partnership with Incremental and Skai drove a 32% boost in iROI, delivering nearly a third more sales per ad dollar.

In a report released today, Richard Vosser from J.P. Morgan maintained a Hold rating on Bayer (0P6S – Research Report), with a price target of ...

As leaders gather for the World Economic Forum Annual Meeting 2025 in Davos, Leaps by Bayer, the impact investing arm of Bayer ... society's need for solutions to climate change, strained healthcare ...

Gadoquatrane, a contrast agent Bayer is developing for use in MRI scans, like those done in MS, uses 60% less gadolinium and ...

The trend toward larger deal sizes is likely to continue as companies seek to bolster their pipelines amid a looming patent ...

The pharmaceutical landscape sees movement beyond the courtroom as Biogen focuses on growth from new product launches rather than acquisitions to drive future revenues. Similarly, Bayer's ...

Oakmark Funds, advised by Harris Associates, released its “Oakmark International Fund” fourth quarter 2024 investor letter. A copy of the letter can be downloaded here. For the quarter ended December ...